Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Services
  • Revvity Omics Services
    • Preclinicalサービス
    • Revvity Omics Services
    • 臨床サービス
    • Customization Services
    • ライセンシング
    • Viral Vector Engineering and Manufacture
    • Instrument Service & Maintenance
    • Customer Training
    • OEM ソリューション
  • Revvity Omics Clinical Services
    • Revvity Omics Clinical Services
    • Revvity Omics Pharma Services
  • Prenatal Screening Services
    • Cytogenomics
    • Global Laboratory Network
    • Metabolic Testing
    • Newborn Screening Services
    • Prenatal Screening Services
    • Proactive Testing
    • Rare Disease Testing
    • Specialized and Customized Assays
    • Sponsored Testing Programs

Prenatal Screening

Prenatal screening for first and second trimester pregnancies

Pregnancy is most often a wonderful time filled with excitement and the anticipation of a new addition to the family. At various stages of your pregnancy - the first and the second trimesters - your doctor may recommend different tests to ensure that your baby is developing normally. Prenatal screening, combined with an ultrasound scan, is advised to monitor fetal development.

prenatal screening

Explore our prenatal screening solutions

first trimester screening

First Trimester Screening

When it comes to risk assessment and diagnosis of prenatal aneuploidy and pre-eclampsia, Revvity Omics offers you a one-stop solution from non-invasive biochemical screening in first trimester to diagnostic testing through cytogenetics, molecular genetics, and genetic counseling.

Learn more
second trimester screening

Second Trimester Screening

From 14 to 26 weeks of pregnancy, the quadruple marker screening can provide expectant parents with crucial information about maternal and fetal health.

Learn more
nipt

Non-invasive Prenatal Testing

Non-invasive prenatal testing (NIPT) is a highly precise and reliable screening test for detecting the most common chromosomal disorders in a baby before birth.

Learn more
全てを表示 View less

This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.

Contact Revvity Omics for more information

Contact us
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.